Daratumumab significantly improved progression- free survival in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma (CROSBI ID 672251)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Katalinic, Darko
engleski
Daratumumab significantly improved progression- free survival in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma
Daratumumab significantly improved progression- free survival in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma
Daratumumab, Lenalidomid, Multiple Myeloma
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
526-526.
2017.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Haematologica
Cools, Jan
Madrid: Haematologica
0390-6078
1592-8721
Podaci o skupu
22nd Congress of the European Hematology Association
poster
22.06.2017-25.06.2017
Madrid, Španjolska
Povezanost rada
Biologija, Dentalna medicina, Kliničke medicinske znanosti, Temeljne medicinske znanosti